Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Indivior Plc (INDV)

Indivior Plc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Indivior Plc 10710 Midlothian Turnpike Suite 125 North Chesterfield VA 23235 USA

www.indivior.com Employees: 1,051 P: 804-379-1040

Sector:

Medical

Description:

Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 4,112,961
Enterprise Value, $K 4,126,961
Shares Outstanding, K 137,880
Annual Sales, $ 1,188 M
Annual Net Income, $ 2,000 K
Last Quarter Sales, $ 314,000 K
Last Quarter Net Income, $ 42,000 K
EBIT, $ 277,000 K
EBITDA, $ 306,000 K
60-Month Beta 0.68
% of Institutional Shareholders 60.33%
Float, K 137,880
% Float 100.00%
Short Volume Ratio 0.17

Growth:

1-Year Return 201.23%
3-Year Return 90.61%
5-Year Return 300.40%
5-Year Revenue Growth 51.34%
5-Year Earnings Growth 44.35%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.72 on 10/30/25
Next Earnings Date N/A
Earnings Per Share ttm 1.96
EPS Growth vs. Prev Qtr 41.18%
EPS Growth vs. Prev Year 33.33%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 10/11/22

INDV Ratios

Ratio
Price/Earnings ttm 15.36
Price/Earnings forward 13.92
Price/Earnings to Growth N/A
Return-on-Equity % -90.79%
Return-on-Assets % 17.91%
Profit Margin % 0.17%
Debt/Equity -1.56
Price/Sales 3.23
Price/Cash Flow 16.53
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -1.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar